Vaccine maker's 1bn UK investment to create hundreds of high-skilled jobs'
Briefly

BioNTech plans to invest up to 1 billion in the UK over the next decade, establishing two new research and development hubs in Cambridge and London, which are expected to create over 400 high-skilled jobs. This investment stands as one of the most substantial in the history of UK life sciences, highlighting the UK’s burgeoning potential in biopharmaceutical innovation. The UK government will match this investment with up to 129 million to support research and economic growth in this vital sector. The collaboration aims to propel advancements in life sciences, leveraging BioNTech's expertise in mRNA vaccines and therapeutics.
"Biopharmaceutical company BioNTech has announced funding of up to 1 billion into the UK over the next 10 years, marking one of the largest investments in UK life sciences."
"The planned investment involves creating two new research and development hubs, which may generate more than 400 jobs in clinical and scientific drug development over the next decade."
Read at www.independent.co.uk
[
|
]